Expansion opportunities Leverage Enalees’ rapid molecular diagnostic capabilities and growing Rhéa product line to propose in-country or regional expansion partnerships, manufacturing collaborations, and lyophilized assay development for additional livestock species and companion animal diseases in Europe.

Distribution partnerships Target distributors like Unisensor SA and other veterinary supply networks to broaden market reach for Rhéa panels and the vector-borne disease tests, emphasizing the company’s proven concept with Covid-19 screening and its enhanced assay portfolio.

Animal health growth Propose bundled offerings combining Rhéa rapid tests with Asteria feline coronavirus kit and upcoming vector-borne panels to veterinary clinics, hospitals, and pharmacies seeking faster, point-of-care diagnostics across canine, feline, and bovine markets.

OEM and Lyophilization Capitalize on Enalees’ lyophilization expertise to offer contract development and manufacturing for partner products in health, agriculture, and environment sectors, creating new revenue streams beyond veterinary diagnostics.

Regional leadership Position Enalees’ France-based production and ongoing DACH and European market expansion as a competitive advantage to attract regional integrators and state-of-health initiatives seeking localized rapid-diagnostic solutions and supply chain resilience.